#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13336	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2271	713.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1479	1479	C	835	C,G	834,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22052	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	654.6	0	.	n	.	0	T695C	SNP	695	695	T	1314	1314	C	875	C,T,G	869,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22052	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	654.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1956	1956	A	934	A,C	933,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22052	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	654.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2590	2590	C	762	C,T,G	760,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22052	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	654.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2664	2664	A	714	A,T,C	712,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22052	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	654.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3216	3216	C	788	C,G,A,T	784,1,1,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1906	folP	855	855	100.0	folP.l15.c4.ctg.1	1930	123.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1228	1230	AGC	202;202;201	A;G;C,T	202;202;200,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4450	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3984	139.3	1	SNP	p	S91F	1	.	.	271	273	TTC	909	911	TTC	179;177;177	T,A;T;C	178,1;177;177	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4450	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3984	139.3	1	SNP	p	G95N	0	.	.	283	285	GGC	921	923	GGC	183;185;186	G,T;G;C	182,1;185;186	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4450	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3984	139.3	1	SNP	p	D95G	1	.	.	283	285	GGC	921	923	GGC	183;185;186	G,T;G;C	182,1;185;186	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1716	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1781	120.3	1	SNP	p	G45D	0	.	.	133	135	GGC	699	701	GGC	179;181;178	G;G;C	179;181;178	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	940	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1535	76.4	0	.	n	.	0	A197.	DEL	197	197	A	880	880	A	194	A	194	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3447	155.7	1	SNP	p	D86N	0	.	.	256	258	GAC	816	818	GAC	239;238;236	G,T;A,G;C	238,1;237,1;236	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3447	155.7	1	SNP	p	R87W	0	.	.	259	261	CGT	819	821	CGT	234;236;235	C,T;G;T	233,1;236;235	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3447	155.7	1	SNP	p	R87I	0	.	.	259	261	CGT	819	821	CGT	234;236;235	C,T;G;T	233,1;236;235	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3447	155.7	1	SNP	p	S87R	1	.	.	259	261	CGT	819	821	CGT	234;236;235	C,T;G;T	233,1;236;235	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3447	155.7	1	SNP	p	S88P	0	.	.	262	264	TCC	822	824	TCC	234;238;239	T;C;C	234;238;239	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3590	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3099	144.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1809	1811	GGC	197;196;192	G,T;G;C	196,1;196;192	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1497	1499	GCA	199;200;201	G;C;A	199;200;201	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1500	1502	ATC	202;205;205	A,T;T;C	201,1;205;205	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1512	1514	GTG	207;211;212	G;T,G;G,T	207;209,2;211,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1512	1514	GTG	207;211;212	G;T,G;G,T	207;209,2;211,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2016	2018	ACC	195;194;196	A,G;C;C	194,1;194;196	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2070	2072	GCG	176;176;178	G;C,G;G	176;174,2;178	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2070	2072	GCG	176;176;178	G;C,G;G	176;174,2;178	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2193	2195	AGC	176;177;175	A;G,T;C	176;176,1;175	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2202	2204	GGC	182;181;180	G;G;C	182;181;180	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3424	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2850	149.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2220	2222	CCG	172;175;179	C,G;C;G,T	171,1;175;178,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4788	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3497	170.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1840	1842	CCG	204;202;201	C;C,T;G	204;201,1;201	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2030	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2309	109.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	791	791	C	155	C	155	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	560	264	porB1a	984	155	92.9	porB1a.l15.c4.ctg.4	155	43.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	21;22;23	T;T;A	21;22;23	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	560	264	porB1a	984	155	92.9	porB1a.l15.c4.ctg.4	155	43.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	54;54;54	C;A;T	54;54;54	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	560	264	porB1a	984	155	92.9	porB1a.l15.c4.ctg.4	155	43.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	54;54;54	A;G;T	54;54;54	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	560	264	porB1a	984	155	92.9	porB1a.l15.c4.ctg.4	155	43.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	54;54;54	T;A;C	54;54;54	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2694	porB1b	1035	1035	98.76	porB1b.l15.c30.ctg.1	1513	211.0	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	957	957	T	228	T	228	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2694	porB1b	1035	1035	98.76	porB1b.l15.c30.ctg.1	1513	211.0	1	SNP	p	G120K	0	.	.	358	360	GGT	684	686	GGT	235;233;232	G,C;G,T;T,C,G	234,1;232,1;230,1,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2694	porB1b	1035	1035	98.76	porB1b.l15.c30.ctg.1	1513	211.0	1	SNP	p	A121N	0	.	.	361	363	GCC	687	689	GCC	233;231;231	G,A;C,T;C,A	232,1;229,2;230,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2694	porB1b	1035	1035	98.76	porB1b.l15.c30.ctg.1	1513	211.0	1	SNP	p	A121D	0	.	.	361	363	GCC	687	689	GCC	233;231;231	G,A;C,T;C,A	232,1;229,2;230,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9204	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5220	219.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1270	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1447	109.4	1	SNP	p	V57M	1	.	.	169	171	ATG	741	743	ATG	226;224;223	A;T;G,A	226;224;222,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
